When SARS-CoV-2 was first identified, many researchers redirected their focus to the study of this novel virus and the disease it causes. Those working with CRISPR were no exception, and the gene editing tool was soon brought to the frontlines in the worldwide war against COVID-19. With the technology based upon a naturally occurring bacterial gene editing system that plays a key role the prokaryotic defense against viral infection, the CRISPR—Cas system is designed to fight viruses. The challenge facing researchers now is how best to utilize its natural ability and optimize it for human benefit. Here, scientists have indeed risen to the occasion and CRISPR technology has been successfully used to develop rapid diagnostic tests for COVID-19 – gaining its first US FDA (MD, USA) approval in the process Click Here For Complete Article Text
|
||||||||||||||||||
| Application Sequencing | ||||||||||||||||||
|
||||||||||||||||||
| Company | Product | Process | Other Subjects | Event | Event Date | Location | Publication | Publication Date | Text Descriptor | |||||||||
|
|
|
|
|
|
|
||||||||||||